Biosidus
Buenos Aires, Argentina· Est.
Argentina‑based biosimilar leader delivering affordable biologics to emerging markets.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $50M
AI Company Overview
Argentina‑based biosimilar leader delivering affordable biologics to emerging markets.
OncologyRheumatologyEndocrinologyImmunology
Technology Platform
A recombinant protein platform using CHO and yeast expression systems, coupled with proprietary purification and formulation processes to produce high‑quality biosimilars.
Opportunities
Expanding biosimilar access in emerging markets and leveraging partnerships for regional distribution.
Risk Factors
Regulatory hurdles, competition from multinational biosimilar manufacturers, and scaling manufacturing capacity.
Competitive Landscape
Competes with global biosimilar players like Sandoz, Amgen, and Pfizer, differentiating through localized patient support and cost‑effective production.